Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2008
A randomized phase II study of ixabepilone (BMS-247550) given daily x 5 days every 3 weeks or weekly in patients with metastatic or recurrent squamous cell cancer of the head and neck: an Eastern Cooperative Oncology Group study
B A Burtness, J Manola, R Axelrod, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland
|
December 2, 2004
Molecular strategies and 111in-labelled somatostatin analogues in defining the management of neuroendocrine tumour disease: a new paradigm for surgical management
I M Modlin, M Kidd, T Hinoue, et al.
Leukemia
|
June 1, 1997
Increased methotrexate polyglutamylation in acute megakaryocytic leukemia (M7) compared to other subtypes of acute myelocytic leukemia
A Argiris, G S Longo, R Gorlick, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 13, 2004
A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer
A Argiris, M Liptay, M LaCombe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 7, 2014
Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trials
A Argiris, S Li, M Ghebremichael, et al.
Investigational New Drugs
|
September 20, 2001
Phase II trial of 9-aminocamptothecin as a 72-h infusion in cutaneous T-cell lymphoma
A Argiris, P Heald, T Kuzel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 7, 2007
Long-term outcomes with concurrent carboplatin, paclitaxel and radiation therapy for locally advanced, inoperable head and neck cancer
S S Agarwala, E Cano, D E Heron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 26, 2003
Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary
A Argiris, S M Smith, K Stenson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 16, 2009
Clinical and dosimetric factors associated with a prolonged feeding tube requirement in patients treated with chemoradiotherapy (CRT) for head and neck cancers
A S Gokhale, B T McLaughlin, J C Flickinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2010
Response assessment by combined PET-CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy
V A Passero, B F Branstetter, Y Shuai, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2008
A randomized phase II study of ixabepilone (BMS-247550) given daily x 5 days every 3 weeks or weekly in patients with metastatic or recurrent squamous cell cancer of the head and neck: an Eastern Cooperative Oncology Group study
B A Burtness, J Manola, R Axelrod, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland
|
December 2, 2004
Molecular strategies and 111in-labelled somatostatin analogues in defining the management of neuroendocrine tumour disease: a new paradigm for surgical management
I M Modlin, M Kidd, T Hinoue, et al.
Leukemia
|
June 1, 1997
Increased methotrexate polyglutamylation in acute megakaryocytic leukemia (M7) compared to other subtypes of acute myelocytic leukemia
A Argiris, G S Longo, R Gorlick, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 13, 2004
A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer
A Argiris, M Liptay, M LaCombe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 7, 2014
Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trials
A Argiris, S Li, M Ghebremichael, et al.
Investigational New Drugs
|
September 20, 2001
Phase II trial of 9-aminocamptothecin as a 72-h infusion in cutaneous T-cell lymphoma
A Argiris, P Heald, T Kuzel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 7, 2007
Long-term outcomes with concurrent carboplatin, paclitaxel and radiation therapy for locally advanced, inoperable head and neck cancer
S S Agarwala, E Cano, D E Heron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 26, 2003
Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary
A Argiris, S M Smith, K Stenson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 16, 2009
Clinical and dosimetric factors associated with a prolonged feeding tube requirement in patients treated with chemoradiotherapy (CRT) for head and neck cancers
A S Gokhale, B T McLaughlin, J C Flickinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2010
Response assessment by combined PET-CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy
V A Passero, B F Branstetter, Y Shuai, et al.
Page
of 3